Journal of Forensic and Legal Medicine
Volume 17, Issue 1 , Pages 46-49 , January 2010

An autopsy case of rhabdomyolysis related to vegetamin and genetic analysis of the rhabdomyolysis-associated genes

  • Aya Matsusue, MS (Assistant Professor)

      Affiliations

    • Department of Forensic Medicine, Faculty of Medicine, Fukuoka University, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 92 801 1011x3335; fax: +81 92 801 4266.
    • ,
  • Kenji Hara, PhD (Senior Assistant Professor)

      Affiliations

    • Department of Forensic Medicine, Faculty of Medicine, Fukuoka University, Japan
    • ,
  • Mitsuyoshi Kageura, PhD (Professor)

      Affiliations

    • General Medical Research Center, Faculty of Medicine, Fukuoka University, Japan
    • ,
  • Masayuki Kashiwagi, MD (Assistant Professor)

      Affiliations

    • Department of Forensic Medicine, Faculty of Medicine, Fukuoka University, Japan
    • ,
  • Wang Lu, MD (PhD Student)

      Affiliations

    • Department of Human Pathology, The University of Tokushima Graduate School, Japan
    • ,
  • Akiko Ishigami, PhD (Assistant Professor)

      Affiliations

    • Department of Forensic Medicine, The University of Tokushima Graduate School, Japan
    • ,
  • Takako Gotohda, PhD (Assistant Professor)

      Affiliations

    • Department of Forensic Medicine, The University of Tokushima Graduate School, Japan
    • ,
  • Itsuo Tokunaga, PhD (Senior Assistant Professor)

      Affiliations

    • Department of Forensic Medicine, The University of Tokushima Graduate School, Japan
    • ,
  • Akiyoshi Nisimura, MD PhD (Professor)

      Affiliations

    • Department of Forensic Medicine, The University of Tokushima Graduate School, Japan
    • ,
  • Tomoko Sugimura, MD (PhD Student)

      Affiliations

    • Department of Forensic Medicine, Faculty of Medicine, Fukuoka University, Japan
    • ,
  • Shin-ichi Kubo, MD PhD (Professor)

      Affiliations

    • Department of Forensic Medicine, Faculty of Medicine, Fukuoka University, Japan

Received 17 December 2008 ,Revised 7 April 2009 ,Accepted 19 July 2009.

References 

  1. Richards JR. Rhabdomyolysis and drugs of abuse. J Emerg Med. 2000;19:51–56
  2. Phillips MS, Fujii J, Khanna VK, et al. The structural organization of the human skeletal muscle ryanodine receptor (RYR1) gene. Genomics. 1996;34:24–41
  3. Robinson R, Carpenter D, Shaw MA, Halsall J, Hopkins P. Mutations in RYR1 in malignant hyperthermia and central core disease. Hum Mutat. 2006;27:977–989
  4. Davis M, Brown R, Dickson A, et al. Malignant hyperthermia associated with exercise-induced rhabdomyolysis or congenital abnormalities and a novel RYR1 mutation in New Zealand and Australian pedigrees. Br J Anaesth. 2002;88:508–515
  5. Wappler F, Fiege M, Steinfath M, et al. Evidence for susceptibility to malignant hyperthermia in patients with exercise-induced rhabdomyolysis. Anesthesiology. 2001;94:95–100
  6. Bieber LL. Carnitine. Annu Rev Biochem. 1988;57:261–283
  7. Kaneoka H, Uesugi N, Moriguchi A, et al. Carnitine palmitoyltransferase II deficiency due to a novel gene variant in a patient with rhabdomyolysis and ARF. Am J Kidney Dis. 2005;45:596–602
  8. Aoki J, Yasuno T, Sugie H, et al. A Japanese adult form of CPT II deficiency associated with a homozygous F383Y mutation. Neurology. 2007;69:804–806
  9. Vianey-Saban C, Divry P, Brivet M, et al. Mitochondrial very-long-chain acyl-coenzyme A dehydrogenase deficiency: clinical characteristics and diagnostic considerations in 30 patients. Clin Chim Acta. 1998;269:43–62
  10. Voermans NC, van Engelen BG, Kluijtmans LA, Stikkelbroeck NM, Hermus AR. Rhabdomyolysis caused by an inherited metabolic disease: very long-chain acyl-CoA dehydrogenase deficiency. Am J Med. 2006;119:176–179
  11. Hargraves JAHW, Racha JK, Levy RH. Identification of enzymes responsible for the metabolism of phenobarbital [abstract]. Int Soc Stud Xenobiotics Proc. 1996;10:259
  12. Nakamura K, Yokoi T, Inoue K, et al. CYP2D6 is the principal cytochrome P450 responsible for metabolism of the histamine H1 antagonist promethazine in human liver microsomes. Pharmacogenetics. 1996;6:449–457
  13. Muralidharan G, Cooper JK, Hawes EM, Korchinski ED, Midha KK. Quinidine inhibits the 7-hydroxylation of chlorpromazine in extensive metabolisers of debrisoquine. Eur J Clin Pharmacol. 1996;50:121–128
  14. Tsukamoto Y, Kuwabara K, Hirota S, et al. Expression of the 150-kd oxygen-regulated protein in human breast cancer. Lab Invest. 1998;78:699–706
  15. Morita J, Kobayashi K, Wanibuchi A, et al. A novel single nucleotide polymorphism (SNP) of the CYP2C19 gene in a Japanese subject with lowered capacity of mephobarbital 4′-hydroxylation. Drug Metab Pharmacokinet. 2004;19:236–238
  16. Ishigami A, Tokunaga I, Gotohda T, Kubo S. Immunohistochemical study of myoglobin and oxidative injury-related markers in the kidney of methamphetamine abusers. Leg Med (Tokyo). 2003;5:42–48
  17. Tokunaga I, Kubo S, Ishigami A, Gotohda T, Kitamura O. Changes in renal function and oxidative damage in methamphetamine-treated rat. Leg Med (Tokyo). 2006;8:16–21
  18. Kimchi-Sarfaty C, Oh JM, Kim IW, et al. A “silent” polymorphism in the MDR1 gene changes substrate specificity. Science. 2007;315:525–528
  19. Taroni F, Verderio E, Fiorucci S, et al. Molecular characterization of inherited carnitine palmitoyltransferase II deficiency. Proc Natl Acad Sci USA. 1992;89:8429–8433
  20. Dorado P, Penas-Lledo EM, Llerena A. CYP2D6 polymorphism: implications for antipsychotic drug response, schizophrenia and personality traits. Pharmacogenomics. 2007;8:1597–1608
  21. Omar MA, Wilson JP, Cox TS. Rhabdomyolysis and HMG-CoA reductase inhibitors. Ann Pharmacother. 2001;35:1096–1107
  22. Frudakis TN, Thomas MJ, Ginjupalli SN, Handelin B, Gabriel R, Gomez HJ. CYP2D6*4 polymorphism is associated with statin-induced muscle effects. Pharmacogenet Genomics. 2007;17:695–707
  23. Sakuyama K, Sasaki T, Ujiie S, et al. Functional characterization of 17 CYP2D6 allelic variants (CYP2D6.2, 10, 14A-B, 18, 27, 36, 39, 47-51, 53-55, and 57). Drug Metab Dispos. 2008;36:2460–2467
  24. Yukawa E, Mamiya K. Effect of CYP2C19 genetic polymorphism on pharmacokinetics of phenytoin and phenobarbital in Japanese epileptic patients using non-linear mixed effects model approach. J Clin Pharm Ther. 2006;31:275–282

PII: S1752-928X(09)00124-3

doi: 10.1016/j.jflm.2009.07.020

Journal of Forensic and Legal Medicine
Volume 17, Issue 1 , Pages 46-49 , January 2010

Article Tools

* Image Usage & Resolution